Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
916 4 |
Ultima descărcare din IBN: 2022-03-29 10:12 |
SM ISO690:2012 ŞCIUCA, Svetlana, SELEVESTRU, Rodica, MORDVINOV, Ghenadie, DANILOV, Tatiana. Programul de recuperare imunologică a elevilor cu astm. In: Analele Ştiinţifice ale USMF „N. Testemiţanu”, 2009, nr. 5(10), pp. 248-254. ISSN 1857-1719. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Analele Ştiinţifice ale USMF „N. Testemiţanu” | ||||||
Numărul 5(10) / 2009 / ISSN 1857-1719 | ||||||
|
||||||
Pag. 248-254 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
The study included 46 children (6 to 14 years) with bronchial asthma with different degree
of severity associated to the infection of the respiratory tract and ORL infection. The children
were supposed to partial randomization in two subgroups by 23 children. The concentration of secretory IgA of nasal secretions in children with bronchial asthma from the basic group was decreased significantly 161,5±18,9mg/L comparison with the concentration of secretory IgA in healthy children 295±20,9mg/L (ð <0,001). Concentration of the secretory IgA in nasal secretions depending upon the therapy from the basic group determined an evident increase equal to 265±28,1mg/L (ð <0,001). |
||||||
|
DataCite XML Export
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'> <creators> <creator> <creatorName>Şciuca, S.S.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Selevestru, R.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Mordvinov, G.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Danilov, T.</creatorName> <affiliation>IMSP Institutul Mamei şi Copiluluii, Moldova, Republica</affiliation> </creator> </creators> <titles> <title xml:lang='ro'>Programul de recuperare imunologică a elevilor cu astm</title> </titles> <publisher>Instrumentul Bibliometric National</publisher> <publicationYear>2009</publicationYear> <relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1857-1719</relatedIdentifier> <dates> <date dateType='Issued'>2009-10-01</date> </dates> <resourceType resourceTypeGeneral='Text'>Journal article</resourceType> <descriptions> <description xml:lang='en' descriptionType='Abstract'>The study included 46 children (6 to 14 years) with bronchial asthma with different degree of severity associated to the infection of the respiratory tract and ORL infection. The children were supposed to partial randomization in two subgroups by 23 children. The concentration of secretory IgA of nasal secretions in children with bronchial asthma from the basic group was decreased significantly 161,5±18,9mg/L comparison with the concentration of secretory IgA in healthy children 295±20,9mg/L (ð <0,001). Concentration of the secretory IgA in nasal secretions depending upon the therapy from the basic group determined an evident increase equal to 265±28,1mg/L (ð <0,001).</description> <description xml:lang='ro' descriptionType='Abstract'>Studiul a inclus 46 de elevi (6-14 ani) cu astm bronsic de diferit grad de severitate comorbid cu infectia ca ilor respiratorii si infectia ORL. Copiii au fost supusi randomizarii partiale în doua subloturi a câte 23 de elevi. Concentratia IgA secretorie din secretiile nazale la copiii cu astm bronsic din lotul de baza a fost semnificativ micsorata 161,5±18,9mg/L comparativ cu concentratia IgA secretorie la copiii sanatosi 295±20,9mg/L, (ð <0,001). Concentratia IgA secretorie în secretiile nazale în functie de tratament la lotul de baza a constatat o crestere evidenta egala cu 265±28,1mg/L, (ð <0,001).</description> </descriptions> <formats> <format>application/pdf</format> </formats> </resource>